利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: Extended scope and efficacy of the AWT.

Introduction: Acoustic Wave Therapy is meanwhile a well established treatment method for multiple aesthetic disorders and rejuvenation treatment. It is a non-invasive treatment using focused and radial shockwaves with practically no noticeable side effects.

Materials / method: The treatment is performed with the “Sepia C-Actor” focused handpiece, “Falcon” radial handpiece and the “V-Actor” vibration handpiece. Additionally “Vacu-Actor” for the release of subcutaneous adhesions can be used.

Results: AWT equipment was significantly upgraded:
• Technical innovations include the replacement of the current “Cellactor” family by “Duolith”, AWT Edition allowing the additional use of the “Sepia FSW” focused handpiece,
doubled focused AWT pulse frequency,
vibration therapy with up to 50Hz,
“Visible Body” software,
monitors with FullHD display and PCAP TouchScreen and
“Soft-Actor” transmitter
• New indications for Mean Health can be successfully treated with our new AWT Edition equipment: Erectile dysfunction and Peyronie’s disease.
Also Women Heath indications might come in the future

Conclusion: The reported AWT innovations further increase the AWT treatment efficacy and indication range.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Storz Medical AG

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: Approval process ongoing
和审阅情况: Soft-Actor transmitter: EP 17 020 149.2 and DP 20 2017 001 951.5

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。 Storz Medical AG